A new study by A.T. Kearney Inc. reports that China has surpassed India and Russia as the top overseas choice for clinical trials among major drug companies. China's advantages are "compelling," says Kearney Vice-President Carol Cruickshank.
Much of the appeal comes down to money.
Running a trial in China may cost as little as 15% of what a company would pay in the West, says Reenita Das, Asia-Pacific vice-president for health care at consulting firm Frost & Sullivan Inc.
BusinessWeek has a good article about this issue.
The China Law Blog agrees:
Much of the appeal comes down to money.
Running a trial in China may cost as little as 15% of what a company would pay in the West, says Reenita Das, Asia-Pacific vice-president for health care at consulting firm Frost & Sullivan Inc.
BusinessWeek has a good article about this issue.
The China Law Blog agrees:
In many ways, China is absolutely perfect for drug trials. First, the cost is low. Second, the population is pretty literate and capable of following directions. Third, there are regulations and so if followed, the foreign drug testing company can legitimately claim to have abided by all laws, which laws are not a joke. Fourth, many Chinese are not on any medication, which is required for some testing and helpful for most testing. We can expect testing in China to continue increasing.
1 comment:
Go ahead and do everything in china. All the businesses, all and everything because it is down to money. What are they going to do once everything is transfered to China?
Turn off the lights in the West?
Post a Comment